ICR scientists develop algorithm that predicts bowel cancer risk in IBD patients
Scientists from the Institute of Cancer Research (ICR), London, UK, have developed an algorithm that can predict whether ...
Researchers identify new genes that predispose the iris to inflammation
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...
Rolling Out15h
Ulcerative colitis and its impact on daily life
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
clinicaladvisor.com17h
IBD and Pregnancy Risks: Few Women Discuss Contraception With Their IBD Specialist
Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.
News Medical17h
Study identifies six genetic regions associated with anterior uveitis
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...
New bowel cancer prediction test is more than 90% accurate
A new DNA test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer in the five years. People with inflammatory bowel disease (IBD) — which includes ...
Groundbreaking Bowel Cancer Test Is 90 Percent Accurate At Predicting Disease In Those At High Risk
Scientists say a groundbreaking new test can predict patients at high risk of developing bowel cancer with 90 per cent ...
Algorithm study 90% accurate predicting bowel cancer
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
gastroenterologyadvisor1d
Omvoh Approved for Moderately to Severely Active Crohn Disease
The Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults.